IVF treatment: a complete guide to the IVF process

Introduction: Demystifying IVF in Modern Clinical Practice

Undergoing fertility treatment is rarely a first step. For most individuals and couples, reaching the decision to explore In Vitro Fertilisation (IVF) follows months—frequently years—of hopeful anticipation, cycle tracking, and emotional exhaustion.

When you first sit down in a specialist's consultation room, medical terms can sound like an unfamiliar dialect: gonadotropins, downregulation, antral follicles, cleavage morphology, blastocyst grading, and luteal support.

The objective of this guide is to demystify IVF entirely. Grounded in clinical guidelines from the American Society for Reproductive Medicine (ASRM 2026), the European Society of Human Reproduction and Embryology (ESHRE), and India's ART Act of 2021, this guide walks you through every physiological, medical, and laboratory milestone of the modern IVF process.

Who Is IVF For? Diagnostic Indications

IVF is not a one-size-fits-all therapy. Modern reproductive medicine utilizes IVF across a wide spectrum of indications: 1. Tubal Factor Infertility: Occluded or damaged fallopian tubes preventing natural gamete encounter. 2. Severe Male Factor Considerations: Significant oligospermia, asthenospermia, or teratospermia requiring ICSI. 3. Endometriosis (Stages III & IV): Structural pelvic adhesions and inflammatory peritoneal environments impairing fertilization. 4. Ovulatory Disorders & PCOS: Cases resistant to conservative oral ovulation induction. 5. Diminished Ovarian Reserve (DOR): Patients seeking to optimize embryo yield within an optimal reproductive window. 6. Unexplained Infertility: Cases where tubal patency, semen analysis, and hormonal profiles are normal, yet pregnancy has not occurred after 12 to 24 months of timed attempts. 7. Preimplantation Genetic Testing (PGT): Parental balanced translocations or monogenic disorders requiring cellular biopsy before transfer.

Step-by-Step Anatomy of a 2026 IVF Cycle

• Phase 1: Baseline Workup (Days 1–3): On Day 2 or 3 of the menstrual cycle, a transvaginal ultrasound measures Antral Follicle Count (AFC) and rules out functional cysts. Serum Estradiol and Progesterone are verified.
• Phase 2: Controlled Stimulation (Days 3–12): Daily gonadotropins encourage multiple follicles to mature co-dominantly. Ultrasounds and blood tests calibrate dosages every 48 to 72 hours.
• Phase 3: The Ovulatory Trigger: Administered when leading follicles reach 17–20 mm. Egg retrieval occurs exactly 35 to 36 hours post-trigger.
• Phase 4: Egg Retrieval (OPU): Conducted under short conscious sedation. A fine ultrasound-guided aspiration needle collects mature oocytes in 15 to 20 minutes without surgical incisions.
• Phase 5: Embryology Cleanroom: In Class-100 cleanroom suites, eggs are paired with isolated motile sperm via conventional culture or precision ICSI.
• Phase 6: Day-5 Blastocyst Culture: Embryos develop in specialized incubators up to Day 5/6, allowing the hardiest blastocysts to self-select for transfer.
• Phase 7: Embryo Transfer: A soft catheter gently places the chosen embryo into the uterus under continuous ultrasound visualization.

What Are Realistic IVF Success Rates?

ASRM and ESHRE caution against deceptive blanket claims. True live-birth rates are age-dependent:

• Under 35 Years: 46% – 54% expected live birth per cycle (~65% euploidy)
• 35 – 37 Years: 38% – 44% expected live birth per cycle (~50% euploidy)
• 38 – 40 Years: 24% – 32% expected live birth per cycle (~35% euploidy)
• 41 – 42 Years: 12% – 18% expected live birth per cycle (~15% euploidy)
• Over 42 Years: 3% – 8% expected live birth per cycle (< 10% euploidy)